Return to Listing

1 result(s) for

PI Name Protocol # Title
Stephen Spurgeon STUDY00021208 A Phase 1B, Multi-center, Open-label Study to determine the Safety, Pharmacokinetics, and Preliminary Efficacy of CC-99282 in combination with Obinutuzumab in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080